First Quadrant’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-24,400
| Closed | -$406K | – | 1015 |
|
|
2017
Q3 | $406K | Buy |
24,400
+400
| +2% | +$6.5K | 0.01% | 590 |
|
|
2017
Q2 | $430K | Sell |
24,000
-20,718
| -46% | -$387K | 0.01% | 561 |
|
|
2017
Q1 | $897K | Buy |
44,718
+42,418
| +1,844% | +$988K | 0.02% | 466 |
|
|
2016
Q4 | $58K | Hold |
2,300
| – | – | ﹤0.01% | 761 |
|
|
2016
Q3 | $54K | Hold |
2,300
| – | – | ﹤0.01% | 779 |
|
|
2016
Q2 | $46K | Hold |
2,300
| – | – | ﹤0.01% | 717 |
|
|
2016
Q1 | $39K | Hold |
2,300
| – | – | ﹤0.01% | 706 |
|
|
2015
Q4 | $51K | Hold |
2,300
| – | – | ﹤0.01% | 660 |
|
|
2015
Q3 | $39K | Sell |
2,300
-2,500
| -52% | -$38.9K | ﹤0.01% | 700 |
|
|
2015
Q2 | $66K | Hold |
4,800
| – | – | ﹤0.01% | 665 |
|
|
2015
Q1 | $66K | Hold |
4,800
| – | – | ﹤0.01% | 632 |
|
|
2014
Q4 | $51K | Sell |
4,800
-7,100
| -60% | -$84.1K | ﹤0.01% | 661 |
|
|
2014
Q3 | $149K | Buy |
11,900
+1,700
| +17% | +$23.7K | ﹤0.01% | 581 |
|
|
2014
Q2 | $140K | Buy |
+10,200
| New | +$133K | ﹤0.01% | 609 |
|
First Quadrant's OME Position: Q4 2017 in Review
First Quadrant sold out of Omega Protein (OME) in Q4 2017, closing a stake of 24,400 shares — an estimated $406K sold.
First Quadrant first reported a position in OME in Q2 2014 and held it in 14 quarters. The position peaked at $897K in Q1 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- First Quadrant reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- First Quadrant sold 24,400 Omega Protein shares in Q4 2017, an estimated $406K.
- First Quadrant first reported a position in Omega Protein in Q2 2014 and held it in 14 quarters.
- First Quadrant's Omega Protein position peaked at $897K in Q1 2017.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on First Quadrant's 13F filing for Q4 2017, filed 23 Jan 2018.